Are Per- and Polyfluoroalkyl Substances Forever Risk Factors for Cardiovascular Disease? [PDF]
Michikawa T.
europepmc +1 more source
Per- and Polyfluoroalkyl Substances (PFAS) Within the Exposome: Cellular and Molecular Mechanisms Underlying a Potential Risk for Cardiac Arrhythmias and Atrial Fibrillation? [PDF]
Plantier M, Naji N, Dupont A, Hiram R.
europepmc +1 more source
Urine-to-Blood Partitioning of Per- and Polyfluoroalkyl Substances in Human Biomonitoring: Implications for Environmental Exposure Analysis and Bioaccumulation Assessment. [PDF]
Ye P, Bai H, Shi J, Dong Z, Luo K.
europepmc +1 more source
Prenatal exposure to per- and polyfluoroalkyl substances and risk of autism spectrum disorder in the California Central Valley, 2004-2010. [PDF]
Osborne K +9 more
europepmc +1 more source
Non-targeted screening of per- and polyfluoroalkyl substances: Advanced methods, challenges, and environmental health. [PDF]
Yang S, Yi H, Ma D, Zeng L.
europepmc +1 more source
Per- and polyfluoroalkyl substances (PFAS) and menstrual cycle characteristics in midlife women: The Study of Women's Health Across the Nation. [PDF]
Harlow SD +6 more
europepmc +1 more source
Associations of mid-childhood per- and polyfluoroalkyl substances and early childhood metals with mid-childhood antibody titers. [PDF]
Smith A +7 more
europepmc +1 more source
A High-Throughput, High-Content Analysis of Dopaminergic Neurodegeneration in <i>Caenorhabditis elegans</i> Exposed to Per- and Polyfluoroalkyl Substances. [PDF]
Benson D, Currie S, Wang JS, Tang L.
europepmc +1 more source
Exposure to Per- and Polyfluoroalkyl Substances and Liver Cancer: A Systematic Review of Animal and Epidemiological Studies. [PDF]
Tanghal RB +9 more
europepmc +1 more source
Per- and polyfluoroalkyl substances (PFAS) exposure and cardiovascular risk: lipid profile as a mediator. [PDF]
Wang X +7 more
europepmc +1 more source

